257 related articles for article (PubMed ID: 12915482)
1. Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse.
Itier JM; Ibanez P; Mena MA; Abbas N; Cohen-Salmon C; Bohme GA; Laville M; Pratt J; Corti O; Pradier L; Ret G; Joubert C; Periquet M; Araujo F; Negroni J; Casarejos MJ; Canals S; Solano R; Serrano A; Gallego E; Sanchez M; Denefle P; Benavides J; Tremp G; Rooney TA; Brice A; Garcia de Yebenes J
Hum Mol Genet; 2003 Sep; 12(18):2277-91. PubMed ID: 12915482
[TBL] [Abstract][Full Text] [Related]
2. Non-motor behavioural impairments in parkin-deficient mice.
Zhu XR; Maskri L; Herold C; Bader V; Stichel CC; Güntürkün O; Lübbert H
Eur J Neurosci; 2007 Oct; 26(7):1902-11. PubMed ID: 17883413
[TBL] [Abstract][Full Text] [Related]
3. Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons.
Goldberg MS; Fleming SM; Palacino JJ; Cepeda C; Lam HA; Bhatnagar A; Meloni EG; Wu N; Ackerson LC; Klapstein GJ; Gajendiran M; Roth BL; Chesselet MF; Maidment NT; Levine MS; Shen J
J Biol Chem; 2003 Oct; 278(44):43628-35. PubMed ID: 12930822
[TBL] [Abstract][Full Text] [Related]
4. Behavioral phenotyping of Parkin-deficient mice: looking for early preclinical features of Parkinson's disease.
Rial D; Castro AA; Machado N; Garção P; Gonçalves FQ; Silva HB; Tomé AR; Köfalvi A; Corti O; Raisman-Vozari R; Cunha RA; Prediger RD
PLoS One; 2014; 9(12):e114216. PubMed ID: 25486126
[TBL] [Abstract][Full Text] [Related]
5. Suppression of Parkin enhances nigrostriatal and motor neuron lesion in mice over-expressing human-mutated tau protein.
Menéndez J; Rodríguez-Navarro JA; Solano RM; Casarejos MJ; Rodal I; Guerrero R; Sánchez MP; Avila J; Mena MA; de Yébenes JG
Hum Mol Genet; 2006 Jul; 15(13):2045-58. PubMed ID: 16698879
[TBL] [Abstract][Full Text] [Related]
6. Loss of locus coeruleus neurons and reduced startle in parkin null mice.
Von Coelln R; Thomas B; Savitt JM; Lim KL; Sasaki M; Hess EJ; Dawson VL; Dawson TM
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10744-9. PubMed ID: 15249681
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of l-DOPA on monoamine metabolism, cell survival and glutathione production in midbrain neuronal-enriched cultures from parkin knockout and wild-type mice.
Casarejos MJ; Solano RM; Menéndez J; Rodríguez-Navarro JA; Correa C; García de Yébenes J; Mena MA
J Neurochem; 2005 Aug; 94(4):1005-14. PubMed ID: 16000163
[TBL] [Abstract][Full Text] [Related]
8. It's a double knock-out! The quaking mouse is a spontaneous deletion of parkin and parkin co-regulated gene (PACRG).
Lockhart PJ; O'Farrell CA; Farrer MJ
Mov Disord; 2004 Jan; 19(1):101-4. PubMed ID: 14743368
[TBL] [Abstract][Full Text] [Related]
9. Impaired in vivo dopamine release in parkin knockout mice.
Oyama G; Yoshimi K; Natori S; Chikaoka Y; Ren YR; Funayama M; Shimo Y; Takahashi R; Nakazato T; Kitazawa S; Hattori N
Brain Res; 2010 Sep; 1352():214-22. PubMed ID: 20620130
[TBL] [Abstract][Full Text] [Related]
10. Neurotoxicity and behavioral deficits associated with Septin 5 accumulation in dopaminergic neurons.
Son JH; Kawamata H; Yoo MS; Kim DJ; Lee YK; Kim S; Dawson TM; Zhang H; Sulzer D; Yang L; Beal MF; Degiorgio LA; Chun HS; Baker H; Peng C
J Neurochem; 2005 Aug; 94(4):1040-53. PubMed ID: 16092945
[TBL] [Abstract][Full Text] [Related]
11. Parkin suppresses the expression of monoamine oxidases.
Jiang H; Jiang Q; Liu W; Feng J
J Biol Chem; 2006 Mar; 281(13):8591-9. PubMed ID: 16455660
[TBL] [Abstract][Full Text] [Related]
12. Decline of striatal dopamine release in parkin-deficient mice shown by ex vivo autoradiography.
Sato S; Chiba T; Nishiyama S; Kakiuchi T; Tsukada H; Hatano T; Fukuda T; Yasoshima Y; Kai N; Kobayashi K; Mizuno Y; Tanaka K; Hattori N
J Neurosci Res; 2006 Nov; 84(6):1350-7. PubMed ID: 16941649
[TBL] [Abstract][Full Text] [Related]
13. Dopamine-dependent neurodegeneration in rats induced by viral vector-mediated overexpression of the parkin target protein, CDCrel-1.
Dong Z; Ferger B; Paterna JC; Vogel D; Furler S; Osinde M; Feldon J; Büeler H
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12438-43. PubMed ID: 14530399
[TBL] [Abstract][Full Text] [Related]
14. Midbrain neuronal cultures from parkin mutant mice are resistant to nitric oxide-induced toxicity.
Solano RM; Menéndez J; Casarejos MJ; Rodríguez-Navarro JA; García de Yébenes J; Mena MA
Neuropharmacology; 2006 Aug; 51(2):327-40. PubMed ID: 16701721
[TBL] [Abstract][Full Text] [Related]
15. Dopamine covalently modifies and functionally inactivates parkin.
LaVoie MJ; Ostaszewski BL; Weihofen A; Schlossmacher MG; Selkoe DJ
Nat Med; 2005 Nov; 11(11):1214-21. PubMed ID: 16227987
[TBL] [Abstract][Full Text] [Related]
16. rAAV-mediated nigral human parkin over-expression partially ameliorates motor deficits via enhanced dopamine neurotransmission in a rat model of Parkinson's disease.
Manfredsson FP; Burger C; Sullivan LF; Muzyczka N; Lewin AS; Mandel RJ
Exp Neurol; 2007 Oct; 207(2):289-301. PubMed ID: 17678648
[TBL] [Abstract][Full Text] [Related]
17. MPTP and DSP-4 susceptibility of substantia nigra and locus coeruleus catecholaminergic neurons in mice is independent of parkin activity.
Thomas B; von Coelln R; Mandir AS; Trinkaus DB; Farah MH; Leong Lim K; Calingasan NY; Flint Beal M; Dawson VL; Dawson TM
Neurobiol Dis; 2007 May; 26(2):312-22. PubMed ID: 17336077
[TBL] [Abstract][Full Text] [Related]
18. Targeted overexpression of the parkin substrate Pael-R in the nigrostriatal system of adult rats to model Parkinson's disease.
Dusonchet J; Bensadoun JC; Schneider BL; Aebischer P
Neurobiol Dis; 2009 Jul; 35(1):32-41. PubMed ID: 19348945
[TBL] [Abstract][Full Text] [Related]
19. Impaired dopamine release and synaptic plasticity in the striatum of parkin-/- mice.
Kitada T; Pisani A; Karouani M; Haburcak M; Martella G; Tscherter A; Platania P; Wu B; Pothos EN; Shen J
J Neurochem; 2009 Jul; 110(2):613-21. PubMed ID: 19457102
[TBL] [Abstract][Full Text] [Related]
20. Parkin-deficient mice are not more sensitive to 6-hydroxydopamine or methamphetamine neurotoxicity.
Perez FA; Curtis WR; Palmiter RD
BMC Neurosci; 2005 Dec; 6():71. PubMed ID: 16375772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
